The newest mania: seeing disease mongering everywhere. by S Nassir Ghaemi

Get full text

A Smartphone-Based Intervention as an Adjunct to Standard-of-Care Treatment for Schizophrenia: Randomized Controlled Trial by S Nassir Ghaemi, Oleksandr Sverdlov, Joris van Dam, Timothy Campellone, Robert Gerwien

Get full text

Clinical research diagnostic criteria for bipolar illness (CRDC-BP): rationale and validity by S. Nassir Ghaemi, Jules Angst, Paul A. Vohringer, Eric A. Youngstrom, James Phelps, Philip B. Mitchell, Roger S. McIntyre, Michael Bauer, Eduard Vieta, Samuel Gershon

Get full text

A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. by Ashwin Patkar, William Gilmer, Chi-un Pae, Paul A Vöhringer, Michael Ziffra, Edward Pirok, Molly Mulligan, Megan M Filkowski, Elizabeth A Whitham, Niki S Holtzman, Sairah B Thommi, Tanya Logvinenko, Antony Loebel, Prakash Masand, S Nassir Ghaemi

Get full text

MIJ821 (onfasprodil) in healthy volunteers: First‐in‐human, randomized, placebo‐controlled study (single ascending dose and repeated intravenous dose) by Baltazar Gomez‐Mancilla, Jeffrey A. Levy, Subramanian Ganesan, Thomas Faller, Gil Issachar, Ziv Peremen, Offir Laufer, Revital Shani‐Hershkovich, Kostas Biliouris, Ela Walker, Mark P. Healy, Oleksandr Sverdlov, Sachin Desai, S. Nassir Ghaemi, Jang‐Ho Cha, Y. Gopi Shanker

Get full text